Dr. Nicholas Farber
Dr. Nicholas FarberUrologist / Urologic Surgeon, American Board of Urology
  • Medical School: University of Pittsburgh School of Medicine

  • Urology Residency: Rutgers Robert Wood Johnson Medical School

  • Men’s Health and Male Fertility Fellow at the Cleveland Clinic Foundation

  • All Major Insurances Accepted

Make appointment


Follicle-stimulating hormone modestly predicts improvement in semen parameters in men with infertility treated with clomiphene citrate

Sperm granuloma masquerading as a supernumerary testis.

Impact of Pathologic Node Positive Renal Cell Carcinoma on Survival in Patients without Metastasis: Evidence in Support of Expanding the Definition of Stage IV Kidney Cancer

Retroperitoneal lymph node dissection as primary treatment for men with testicular seminoma: utilization and survival analysis using the National Cancer Database

Vasovasostomy: Kinetics and Predictors of Patency

Reasons that Should Prompt a Referral to a Reproductive Urologist: Guidelines for the Gynecologist and Reproductive Endocrinologist

Accuracy of Clinical Nodal Staging in Patients Undergoing Surgery for Renal Cell Carcinoma

Testicular Torsion in Brothers: Case Report and Literature Review

Comparing Outcomes of Medical Management and Minimally Invasive Surgical Techniques for Lower Urinary Tract Symptoms due to BPH

Urologists’ estimations of the cost of commonly used disposable devices

The Urology Match Process and the Limited Value of Post-Interview Communication for Program Directors

Accuracy of Nodal Staging and Outcomes of Lymphadenectomy for Non-metastatic Renal Cell Carcinoma: An Analysis of the National Cancer Database

Trends and Outcomes of Lymphadenectomy for Non-metastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer Database

The Kinetics of Sperm Return and Failure Following Vasovasostomy or Vasoepididymostomy: A Review

Contemporary Practice Patterns in the Treatment of Pediatric Stone Disease

Effect of alvimopan on gastrointestinal recovery and hospital length of stay after retroperitoneal lymph node dissection for testicular cancer.

The Urology Match and Post-Interview Communication

Longitudinal Recovery Patterns of Penile Length and the Underexplored Benefit of Long-Term Phosphodiesterase-5 Inhibitor Use after Radical Prostatectomy.


Dr. Nicholas Farber


Dr. Nicholas Farber graduated magna cum laude from the University of Pittsburgh where he was a Chancellor’s Scholar. He then studied at the University of Pittsburgh School of Medicine, where he was elected to Alpha Omega Alpha, the most prestigious medical honor society. He completed his urologic surgery residency at Rutgers Robert Wood Johnson University Hospital in New Jersey and was recognized for his performance with awards including “Outstanding Minimally Invasive Surgeon” and “Highest Training Examination Score.” Upon graduation, he earned the position of Men’s Health and Male Fertility Fellow at the Cleveland Clinic Foundation, which U.S. News and World Report frequently ranks as the #1 urologic surgery program in the country.

Dr. Farber has extensive training in all aspects of urology for both male and female patients, with particular expertise in minimally invasive treatments for benign prostatic hyperplasia (BPH), Men’s Health (penile implant surgery, low testosterone, erectile dysfunction, Peyronie’s disease, and rapid recovery, no-scalpel vasectomy), male infertility (vasectomy reversal, varicocele, sperm retrieval, treatment of low sperm count), and minimally invasive treatments for overactive bladder in men and women (including Botox and Interstim). In addition, he has extensive experience treating both urologic cancers and benign urologic conditions using minimally invasive robotic surgery. Dr. Farber has participated in hundreds of robotic procedures using Intuitive Surgical’s DaVinci™ Xi and Si platforms, and has presented cutting edge robotic surgical techniques to other urologists at the North American Robotic Urology Symposium (NARUS). He is a leader in the field of urology, having published over 100 combined peer-reviewed manuscripts, abstracts, and book chapters and presented novel research findings to both national and international audiences.

Dr. Farber has been designated as a Urolift Center of Excellence. Physicians that hold a Center of Excellence have achieved a high level of training with the Urolift System and demonstrated a commitment to care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH)

Patients of Dr. Farber will appreciate his sincere concern, careful listening, and sensitivity when dealing with delicate issues. He stays up-to-date with the latest advances in the field, and is passionate about providing innovative, state of the art care for each and every patient. He prides himself on delivering compassionate care tailored to his patient’s needs.